About
The Interagency Pharmaceutical Group (IPC) was established more than 25 years ago on the initiative of the Swedish Government to address the need for better collaboration amongst development partners as a means of improving access to and use of safe, effective, quality assured medicines.
IPC includes senior pharmaceutical advisers from UN agencies and from other agencies in official relations with WHO. Members meet regularly, with bi-annual in-person meetings, to share information on respective agencies’ programmes, achievements and challenges in medicines policy. More specifically, to:
explore areas of common interest and synergies for collaboration;
coordinate the underlying pharmaceutical policies of technical advice to countries; and
plan and coordinate the preparation of interagency statements and technical documents
Collaboration amongst the different agencies has led a better exchange of information, more consistency in the technical advice given and to improve use and access to resources across partners. There are a number of interagency guidance documents published and implemented through the collaboration amongst the members of this group.